In this model, tumor-specific loss of Arf6 significantly reduced tumor growth to a level equivalent to PtenWT tumors (measured from the time of tumor formation, Fig. 3g), and prolonged overall survival despite the absence of PTEN (Fig. 3h). The gene discussed is PTEN; the disease is neoplasm.